SERAX Drug Patent Profile

✉ Email this page to a colleague

When do Serax patents expire, and when can generic versions of Serax launch?

Serax is a drug marketed by Alpharma Us Pharms and is included in one NDA.

The generic ingredient in SERAX is oxazepam. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the oxazepam profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Serax

A generic version of SERAX was approved as oxazepam by TRUPHARMA on August 10^th, 1987.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for SERAX?
What are the global sales for SERAX?
What is Average Wholesale Price for SERAX?

Summary for SERAX

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	43
Patent Applications:	5,463
DailyMed Link:	SERAX at DailyMed

Drug patent expirations by year for SERAX

US Patents and Regulatory Information for SERAX

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alpharma Us Pharms	SERAX	oxazepam	CAPSULE;ORAL	015539-002	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Alpharma Us Pharms	SERAX	oxazepam	TABLET;ORAL	015539-008	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Alpharma Us Pharms	SERAX	oxazepam	CAPSULE;ORAL	015539-004	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Alpharma Us Pharms	SERAX	oxazepam	CAPSULE;ORAL	015539-006	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for SERAX

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Alpharma Us Pharms	SERAX	oxazepam	CAPSULE;ORAL	015539-002	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Alpharma Us Pharms	SERAX	oxazepam	CAPSULE;ORAL	015539-006	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Alpharma Us Pharms	SERAX	oxazepam	CAPSULE;ORAL	015539-004	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for SERAX

See the table below for patents covering SERAX around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Japan	S6036424	MEDICINAL COMPOSITION CONTAINING LIQUID LUBRICATING AGENT	⤷ Sign Up
United Kingdom	8417154		⤷ Sign Up
Australia	569902		⤷ Sign Up
Canada	1235661	PRODUIT PHARMACEUTIQUE A TENEUR DE LUBRIFIANT LIQUIDE (PHARMACEUTICAL COMPOSITION CONTAINING A LIQUID LUBRICANT)	⤷ Sign Up
South Africa	8405180		⤷ Sign Up
Germany	3424975		⤷ Sign Up
Australia	3035684		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for SERAX

Make Better Decisions: Try a trial or see plans & pricing